1 March 2018 in Infection, Genetics and Evolution
1 November 2017 in International Journal of Biological Macromolecules
1 May 2002 in Journal of Virology
The Epstein-Barr virus-encoded latent infection membrane protein 1 (LMP1) is a pleiotropic protein, the activities of which include effects on cell transformation and phenotype, growth, and survival. The ability of LMP1 to mediate at least some of these phenomena could be attributed to the activation of the transcription factor NF-κB. LMP1 promotes NF-κB activation through the recruitment of the adapter protein TRAF2 and the formation of a dynamic multiprotein complex that includes the NF-κB kinase, the IκB kinases, and their downstream targets, IκBs and p105. In this study, we have identified the oncogenic kinase Tpl-2/Cot as a novel component of LMP1-induced NF-κB signaling. We show that Tpl-2 is expressed in primary biopsies from patients with nasopharyngeal carcinoma and Hodgkin's disease, where LMP1 is also found. Inducible expression of LMP1 promotes the activation of Tpl-2, and a catalytically inactive Tpl-2 mutant suppresses LMP1-induced NF-κB signaling. In colocalization and coimmunoprecipitation experiments, Tpl-2 and TRAF2 were found to interact with Tpl-2 functioning downstream of TRAF2. Consistent with this observation, catalytically inactive Tpl-2 also blocked CD40-mediated NF-κB activation, which largely depends on TRAF2. The ability of Tpl-2 to influence LMP1-induced NF-κB occurs through modulation of both IκBα and p105 functions. Furthermore, Tpl-2 was found to influence the expression of angiogenic mediators, such as COX-2 in LMP1-transfected cells. These data identify Tpl-2 as a component of LMP1 signaling downstream of TRAF2 and as a modulator of LMP1-mediated effects.
1 October 2018 in Reviews and Research in Medical Microbiology
Probiotics include a group of microorganisms with numerous effects acting as normal flora and masking binding sites of pathogens and inhibition of their colonization. Most common probiotic species include Bifidobacterium spp., Lactobacilli and Saccharomyces boulardii. Some other beneficial properties of probiotics include cancer prevention, reduction of blood cholesterol and its absorption from the intestine (by bile digestion), stimulation and strengthen of the immune system, treatment and prevention of acute diarrhea, reducing inflammation in the intestines, and food allergies or eczema in children, improving the symptoms of irritable bowel syndrome and colitis, and remedy of vaginal yeast infections, and also antibiotics associated diarrhea, oral lesions, dental caries, and vaginal swelling. Furthermore, probiotics contribute to prevent viral infections, athlete's foot and fungal infections, and improvement of digestion and enhancing nutrition absorbance, inhibition of biofilm formation and increase in vitamins biosynthesis; especially those in groups B and K. Probiotics use in defined amounts has desirable outcomes. Side effects of probiotics are rare which occur among immunocompromised patients and pediatrics, thus care should be taken to avoid their side effects. Use of germ-free animals and study of symbiotic interactions among probiotics is possibly helpful for future perspectives.
5 February 2012 in Molecular Biology Reports
1 June 2014 in Colloids and Surfaces B: Biointerfaces